Estonia - Esti - Ravimiamet

oÜ centralpharma communications - sildenafiil - õhukese polümeerikattega tablett - 100mg 8tk; 100mg 1tk; 100mg 4tk; 100mg 2tk

Estonia - Esti - Ravimiamet

oÜ centralpharma communications - sildenafiil - õhukese polümeerikattega tablett - 50mg 8tk

Estonia - Esti - Ravimiamet

fresenius kabi ab - kombinatsioonid - infusiooniemulsioon - 1970ml 4tk; 1477ml 4tk; 2463ml 3tk; 2463ml 2tk; 493ml 1tk; 1477ml 1tk; 986ml 1tk; 986ml 4tk; 493ml 6tk; 1970ml 1tk; 1970ml 2tk

Estonia - Esti - Ravimiamet

fresenius kabi ab - kombinatsioonid - infusiooniemulsioon - 1970ml 4tk; 1477ml 1tk; 493ml 6tk; 986ml 1tk; 2463ml 3tk; 493ml 1tk; 1970ml 1tk; 1970ml 2tk; 2463ml 1tk

Estonia - Esti - Ravimiamet

ast farma - doksütsükliin - suukaudne lahus - 10mg 1ml 30ml 1tk

Estonia - Esti - Ravimiamet

laboratoires serb - pralidoksiim - süstelahuse pulber ja lahusti - 20mg 1ml 10ml 10tk

Uni Eropa - Esti - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmoloogilised vahendid - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Estonia - Esti - Ravimiamet

central pharma contract packing limited - progesteroon - vaginaalgeel - 80mg 1g 1.125g 15tk

Estonia - Esti - Ravimiamet

oÜ centralpharma communications - sildenafiil - õhukese polümeerikattega tablett - 25mg 4tk; 25mg 2tk

Estonia - Esti - Ravimiamet

fresenius kabi ab - elektrolüüdid - infusioonilahuse kontsentraat - 10ml 20tk